The Filing Desk

CONMED vs Embecta

CONMED CNMD · Embecta EMBC · Health Care Equipment

CONMED reported revenue of $1.4 billion in fiscal 2025, 1.3 times Embecta's $1.1 billion in fiscal 2025. CONMED's revenue grew 5.2% in its latest year, and Embecta's fell 3.8%. CONMED had an operating margin of 7.5%, against 22.4% at Embecta. Free cash flow was $151 million at CONMED and $182 million at Embecta. Their fiscal years end in different months (December 31 and September 30), so the periods don't line up exactly.

Side by side

CONMEDEmbecta
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Sep 30, 2025
Revenue$1.4B$1.1B
Revenue growth5.2%−3.8%
Revenue growth a year, last 5 years9.8%−0.1%
Gross margin54.6%62.6%
Operating margin7.5%22.4%
Net margin3.4%8.8%
Free cash flow$151M$182M
Free cash flow margin11.0%16.9%
Return on capital3.7%29.3%
Net debt to EBITDA5.1x4.3x
Dividends and buybacks$25M$35M
Change in diluted share count−0.0%1.0%
Last close$46.38$6.19
P/E at the last close30.7×4.2×
Insider trades, last 12 monthssold $10,591bought $557,850, sold $37,003
Piotroski F-score6 of 96 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
CONMEDEmbecta
Operating margin
Percent of revenue
CONMEDEmbecta
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
CONMEDEmbecta

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the CONMED and Embecta pages.